This should lead to increased levels of LCA at birth. LCA, cholic acid (CA) and chenodeoxycholic acid (CDCA) were quantitated in stored dried blood from six newborn infants with EHBA and fourteen ...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

Post gallbladder removal surgery, your body might struggle with fat digestion, resulting in problems like discomfort, bloating, and various other digestive issues. A potential remedy for this ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the third quarter 2024 and provided a business update. "The Mirum team executed ...

As well as having a role in lipid absorption, bile acids can act as endocrine-signaling molecules. With previous studies suggesting that bile acids operate as metabolic integrators, Watanabe et al.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting ...

The present study suggests the proportions of patients with reflux esophagitis rise up with the increase of GerdQ score, however, a low GerdQ score cannot exclude the possibility of reflux ...

However, there is marked heterogeneity in the methodology that makes direct comparison of these studies difficult. Such heterogeneity includes symptom definition (daily-to-monthly reflux symptoms ...

Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, CHOLBAM® (cholic acid) capsules, and CHENODAL® (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the ...

Q3 2024 Earnings Call Transcript October 31, 2024 Travere Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...